Search

everythinglearnresearchcommunity

for

Search:↓

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Belimumab may cause hair loss in lupus patients.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Baricitinib works better than methotrexate for severe alopecia areata.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Tofacitinib is effective and safe for treating alopecia areata.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.